LuAlva Tablets 20 mg (Leflunomide)

Adult dose

Administer 100mg once daily for 3 days as a loading dose. Administer 20mg once daily as the maintenance dose in patients with rheumatoid arthritis. The maintenance dose should not exceed 20mg once daily. If the patient has poor clinical tolerability, the maintenance dose may be reduced to 10mg once daily. Administer 20mg once daily as the maintenance dose in patients with psoriatic arthritis.

This medication remains in the body for a long time, and adverse reactions may continue even after discontinuation of treatment; therefore, prompt treatment to remove the drug from the body may be necessary if serious side effects occur. It may affect liver function, so caution should be exercised in patients with impaired liver function, and it should not be administered to patients with severe liver damage. Frequent liver function tests are required before administration and at the onset of treatment, and dose adjustments or discontinuation may be necessary if liver enzyme levels increase. It has the potential to suppress immune function, therefore is not recommended for patients with serious infections or immunodeficiencies, and immediate consultation with a physician is necessary if infection symptoms appear. Patients with lung disease or a history of pneumonia should carefully evaluate their lung health status when using this medication, and if symptoms such as dyspnea or cough occur, immediate examination is required. Severe allergic reactions or ulcers may occur on the skin; thus, if any skin abnormal symptoms appear, the drug should be discontinued, and medical consultation should be sought. Women who are pregnant or may become pregnant should not take this medication, as it may be dangerous to the fetus, and if pregnancy is confirmed during treatment, immediate consultation with a physician is needed. This medication should not be administered to patients with hereditary lactose intolerance. Safety in pediatrics has not been established, so it is recommended not to use this medication in those under 18 years of age. This medication may interact with other drugs; therefore, it is essential to inform the doctor or pharmacist of any other medications being taken. In cases of overdose, diarrhea, abdominal pain, and blood abnormalities may occur, and drug removal treatment may be required. The medication should be stored away from direct sunlight and at a temperature of 25 degrees Celsius, and the storage temperature should be maintained within the range of 15-30 degrees Celsius.

• Diarrhea
• elevation of liver enzymes (ALT, AST)
• hair loss
• rash
• weakness
• flu-like syndrome
• upper respiratory infection
• injury
• pain
• abdominal pain

This medication is sensitive to light and should be stored in a container that blocks light. Additionally, to maintain the effectiveness of the drug, it is essential to store it at a cool temperature below 25 degrees Celsius.

Appearance

Yellow to pale yellow triangular film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle